Real-World Experience of People with Hemophilia A Receiving Turoctocog Alfa Pegol (N8-GP): Results from a Patient Experience Survey.
Hermann EichlerAzusa NagaoJohn WallerAlexander StuberPublished in: Patient preference and adherence (2023)
Lower frequency of injections, storage flexibility and improved QoL drove satisfaction and preference for N8-GP over previous treatments among patients with HA.
Keyphrases